Russian pharmaceutical market may grow by 8% in 2016

18 January 2016
moscow-big

Prices for drugs in Russia will increase by 10%-15% this year, which, however will be significantly lower than in 2015, when the price hikes was equivalent to 22.8%, compared to the previous year, according to data of the Russian Federal State Statistics Service, reports The Pharma Letter’s local correspondent.

According to preliminary data of DSM Group, one of Russia’s leading analyst agencies in the field of pharmaceutical sector, in 2015 the Russian pharmaceutical market grew by almost 12%, compared to 2014 - to 1.28 trillion roubles ($16.5 billion), in value terms. According to the analysts, the market increase was mainly due to inflation and the ever growing drug prices.

According to spokesmen of some Russian leading pharmacies, the purchasing power of Russian consumers is steadily declining, which is mainly due to the crisis, while customers are forced to cheaper drugs, and in particular generics of Indian and Russian origin.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical